Refining surgical therapy of liver cancer in cirrhosis: etiology makes the difference.
作者信息
Colombo Massimo, Lleo Ana
机构信息
Humanitas Clinical and Research Center, Rozzano, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
出版信息
Transl Gastroenterol Hepatol. 2018 Dec 14;3:104. doi: 10.21037/tgh.2018.12.03. eCollection 2018.
Abstract
摘要
相似文献
1
Refining surgical therapy of liver cancer in cirrhosis: etiology makes the difference.优化肝硬化患者肝癌的手术治疗：病因至关重要。
Transl Gastroenterol Hepatol. 2018 Dec 14;3:104. doi: 10.21037/tgh.2018.12.03. eCollection 2018.
2
[Regional difference in the etiology of liver cirrhosis in Iwate].[岩手县肝硬化病因的地区差异]
Nihon Shokakibyo Gakkai Zasshi. 1997 Dec;94(12):826-33.
3
[Role of combined etiology (alcohol and B virus) in the development of hepatocarcinoma in subjects with liver cirrhosis].[联合病因（酒精与B病毒）在肝硬化患者肝癌发生中的作用]
Recenti Prog Med. 1989 May;80(5):233-6.
4
Are different cut-off values of liver stiffness assessed by transient elastography according to the etiology of liver cirrhosis for predicting significant esophageal varices?根据肝硬化病因，通过瞬时弹性成像评估的不同肝硬度临界值对预测显著食管静脉曲张是否有意义？
Med Ultrason. 2013 Jun;15(2):111-5. doi: 10.11152/mu.2013.2066.152.is1ir2.
5
Etiology of human liver cancer: controlled prospective study in liver cirrhosis.人类肝癌的病因：肝硬化的对照前瞻性研究
J Toxicol Environ Health. 1979 Mar-May;5(2-3):281-99. doi: 10.1080/15287397909529750.
6
Etiology of liver cirrhosis in Mexico.墨西哥肝硬化的病因
Ann Hepatol. 2004 Jan-Mar;3(1):30-3.
7
Cancer antigen-125 and ICAM-1 are together responsible for ascites in liver cirrhosis.癌抗原125和细胞间黏附分子-1共同导致肝硬化腹水。
Clin Lab. 2014;60(4):653-8. doi: 10.7754/clin.lab.2013.130403.
8
Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosis.
Acta Diabetol. 2014;51(3):455-60. doi: 10.1007/s00592-013-0538-y. Epub 2013 Dec 19.
9
Changing Etiology in Liver Cirrhosis in Sapporo, Japan.日本札幌肝硬化病因的变化
Euroasian J Hepatogastroenterol. 2018 Jan-Jun;8(1):77-80. doi: 10.5005/jp-journals-10018-1266. Epub 2018 May 1.
10
[The course of liver cirrhosis not preceded by viral hepatitis with p articular reference to toxic etiology].[无病毒性肝炎病史的肝硬化病程，特别提及毒性病因]
Pol Tyg Lek. 1991;46(14-16):262-5.
本文引用的文献
1
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南：肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
2
Hepatocellular carcinoma.肝细胞癌。
Lancet. 2018 Mar 31;391(10127):1301-1314. doi: 10.1016/S0140-6736(18)30010-2. Epub 2018 Jan 5.
3
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.《亚太地区肝细胞癌管理临床实践指南：2017年更新版》
Hepatol Int. 2017 Jul;11(4):317-370. doi: 10.1007/s12072-017-9799-9. Epub 2017 Jun 15.
4
Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?手术切除在治疗肝细胞癌方面优于移植吗？
Ann Surg. 2011 Sep;254(3):527-37; discussion 537-8. doi: 10.1097/SLA.0b013e31822ca66f.
5
Liver transplantation for hepatocellular carcinoma.肝细胞癌的肝移植
Ann Surg Oncol. 2008 Apr;15(4):1001-7. doi: 10.1245/s10434-007-9559-5. Epub 2008 Jan 31.
6
Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival.符合米兰标准的肝细胞癌肝硬化患者接受手术切除和肝移植后的肿瘤侵袭性差异：对长期生存的影响
Ann Surg. 2007 Jan;245(1):51-8. doi: 10.1097/01.sla.0000225255.01668.65.
7
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.早期肝细胞癌手术治疗的意向性分析：肝切除术与肝移植术的比较
Hepatology. 1999 Dec;30(6):1434-40. doi: 10.1002/hep.510300629.
Zotero 插件